ZBIO
Zenas BioPharma, Inc.
Phase 3
Confirmed
obexelimab
Immunoglobulin G4-Related Disease (IgG4-RD)
202d ago
~ Jan 31, 2026
SEC 8-K
verified 2mo ago
Countdown card →